Becton Dickinson to acquire Bard for $24bn

Medical technology company Becton Dickinson (BD) will acquire C R Bard, a business in the same industry, for $24 billion.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Fenwick hires NY partner to advise on regulatory matters

2 November 2026 New partner joins from Goodwin, where he was a life sciences partner, bringing experience in healthcare transactions, and regulatory and strategic counselling, among other areas.

Regulation & Industry

UK unveils £1bn sector investment push after recent setbacks

30 October 2026 With its goal of becoming a global life sciences leader still some way off, the UK is betting on new investment, AI and regulatory changes to help close the gap, according to the government’s autumn budget.

Careers

Justice Joanna Smith appointed to interim High Court role as Sir Colin Birss replaces Sir Geoffrey Vos

30 October 2026 Mrs Justice Joanna Smith becomes deputy president of the Business and Property Division of the UK High Court, as Sir Colin Birss fills Sir Geoffrey Vos’ shoes as master of the rolls upon his retirement.

More features

Fenwick hires NY partner to advise on regulatory matters

UK unveils £1bn sector investment push after recent setbacks

Justice Joanna Smith appointed to interim High Court role as Sir Colin Birss replaces Sir Geoffrey Vos

Oura targets Ultrahuman’s redesigned smart ring following import ban

Weil collapse leaves IP talent facing uncertain future after major expansion

Meril turns the tables on Edwards with European patent revocation

Latham lands pharma and tech expert in London

Regeneron and Amgen call a truce on two Eylea biosimilar patents

Becton Dickinson to acquire Bard for $24bn

More on this story

Editor's picks

Editor's picks

More features